Literature DB >> 1566915

Canine coronary vasodepressor responses to hypoxia are attenuated but not abolished by 8-phenyltheophylline.

S C Lee1, R T Mallet, Y Shizukuda, A G Williams, H F Downey.   

Abstract

The purpose of this study was twofold: 1) to verify a report that a suspension of 8-phenyltheophylline (8-PT) completely abolished hypoxia-induced coronary vasodilation [H. M. Wei, Y. H. Kang, and G. F. Merrill. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1043-H1048, 1989] and 2) to determine the effect of dissolved 8-PT on hypoxic hyperemia. The left anterior descending coronary artery of anesthetized dogs was cannulated and perfused at either constant flow or constant pressure. An 8-PT suspension (40 micrograms.kg-1.min-1) produced a twofold elevation of coronary perfusion pressure at constant flow, a 97% decrease in coronary flow at constant pressure, and regional akinesia in both conditions. The coronary vasculature was unresponsive to 60-s coronary occlusion, exogenous adenosine, and hypoxia after infusion of the 8-PT suspension. These findings are consistent with obstruction of the coronary microvasculature by the 8-PT suspension. An 8-PT solution (40 micrograms.kg-1.min-1) produced 95 +/- 3% (P less than 0.001, n = 6) attenuation of exogenous adenosine-induced vasodilation at constant pressure, a 28 +/- 5% (P less than 0.01, n = 6) attenuation of reactive hyperemia, and a 24 +/- 6% (P less than 0.05, n = 6) decrease in hypoxia-induced vasodilation. An 8-PT solution had no effect on systolic segment length shortening and myocardial oxygen consumption. We conclude that 8-PT, when in solution, attenuates but does not abolish the coronary vasodilatory response to hypoxia. Hence, adenosine appears to contribute to hypoxia-induced vasodilation but is not uniquely responsible for the hyperemic response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566915     DOI: 10.1152/ajpheart.1992.262.4.H955

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

2.  Mediators of coronary reactive hyperaemia in isolated mouse heart.

Authors:  Amanda J Zatta; John P Headrick
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 3.  Disentangling the Gordian knot of local metabolic control of coronary blood flow.

Authors:  Johnathan D Tune; Adam G Goodwill; Alexander M Kiel; Hana E Baker; Shawn B Bender; Daphne Merkus; Dirk J Duncker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-08       Impact factor: 4.733

4.  Adenosine concentration in the porcine coronary artery wall and A2A receptor involvement in hypoxia-induced vasodilatation.

Authors:  Ole Frøbert; Gesine Haink; Ulf Simonsen; Claus H Gravholt; Max Levin; Andreas Deussen
Journal:  J Physiol       Date:  2005-11-10       Impact factor: 5.182

5.  Investigation of mechanisms that mediate reactive hyperaemia in guinea-pig hearts: role of K(ATP) channels, adenosine, nitric oxide and prostaglandins.

Authors:  M P Kingsbury; H Robinson; N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

6.  Contribution of prostaglandins in hypoxia-induced vasodilation in isolated rabbit hearts. Relation to adenosine and KATP channels.

Authors:  N Nakhostine; D Lamontagne
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

7.  Regulation of myocardial oxygen delivery in response to graded reductions in hematocrit: role of K+ channels.

Authors:  Alexander M Kiel; Adam G Goodwill; Jillian N Noblet; April L Barnard; Daniel J Sassoon; Johnathan D Tune
Journal:  Basic Res Cardiol       Date:  2017-09-30       Impact factor: 17.165

8.  Coronary artery reperfusion: The ADP receptor P2Y(1) mediates early reactive hyperemia in vivo in pigs.

Authors:  Goran K Olivecrona; Matthias Gotberg; Jan Harnek; Lingwei Wang; Kenneth A Jacobson; David Erlinge
Journal:  Purinergic Signal       Date:  2004-12       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.